Company intelligence / Profile preview
EQL Pharma
Lund, Skåne County, Swedeneqlpharma.com ↗
- Ownership
- Private
- Employees
- ~21
- Development stage
- Other
01
Overview
EQL Pharma develops, markets, and sells cost-efficient generic medicines—primarily niche products without patent protection—to pharmacies and hospitals across Sweden, Denmark, Norway, Finland, and broader Europe. The company’s portfolio includes both inpatient injection products and outpatient formulations. It does not focus on a single therapeutic area but rather identifies opportunities for limited competition generics in the Nordic market. No clinical trial results are reported as their business model centers around established molecules.
- Therapeutic areas
- Infectious DiseasesImmunologyEndocrinologyCardiovascular
- Modalities
- Small molecule (generic medicines)Injection productsFormulations for outpatient care
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Partners in Asia, Europe, India for development activities.
Beyond the preview
Go deeper on EQL Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EQL Pharma.